Primary liver cancer is a challenging global health concern with an estimated more than a
million persons to be affected annually by the year 2025. The commonest type is …

Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world with rising
incidence. Globally, there has been substantial variation in prevalence of risk factors for …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Purpose This guideline provides evidence-based recommendations for the indications and
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …

Background Transarterial radioembolization (TARE) is increasingly used as an alternative to
transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma …

Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …

The high mortality rate associated with hepatocellular carcinoma (HCC) is partly due to the
high proportion of patients who present with advanced stage disease at diagnosis, for whom …

Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …

Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

肝癌发生发展机制的研究进展及其治疗现状 Page 1 第27 卷第7 期 2018 年7 月 中国普通外科
杂志 Chinese Journal of General Surgery Vol.27 No.7 Jul. 2018 © 版权归中国普通外科杂志 …